logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Harm Westdorp

radboud university nijmegen
H指数:20
被引数:1,493

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

NEOadjuvant Dendritic cell therapy added to first line standard of care in advanced epithelial Ovarian Cancer (NEODOC): protocol of a first-in-human, exploratory, single-centre phase I/II trial in the Netherlands

新辅助树突状细胞疗法联合一线标准治疗方案在晚期上皮性卵巢癌中的应用（NEODOC）：一项在荷兰开展的首次人体、探索性、单中心I/II期临床试验方案

BMJ OPEN
IF2.3
2025-11-093
OA
Koeneman, Bouke; Schreibelt, Gerty; Duiveman-de Boer, Tjitske; Bos, Kevin; van Oorschot, Tom; Pots, Jeanette; Scharenborg, Nicole; de Boer, Annemiek; Hins-de Bree, Simone; de Haas, Nienke; de Goede, Anna; Westdorp, Harm; van Ham, Maaike; de Vries, I. Jolanda M.; Ottevanger, Petronella B.
Early On-treatment Circulating Tumor DNA Measurements and Response to Immune Checkpoint Inhibitors in Advanced Urothelial Cancer

晚期尿路上皮癌治疗早期循环肿瘤DNA测量和对免疫检查点抑制剂的反应

EUROPEAN UROLOGY ONCOLOGY
IF9.3
2024-04-012
OA
Tolmeijer, Sofie H.; van Wilpe, Sandra; Geerlings, Maartje J.; von Rhein, Daniel; Smilde, Tineke J.; Kloots, Iris S. H.; Westdorp, Harm; Coskunturk, Mustafa; Oving, Irma M.; van Ipenburg, Jolique A.; van der Heijden, Antoine G.; Hofste, Tom; Weiss, Marjan M.; Schalken, Jack A.; Gerritsen, Winald R.; Ligtenberg, Marjolijn J. L.; Mehra, Niven
Impact of TP53 loss-of-function alterations on the response to PSMA radioligand therapy in metastatic castration-resistant prostate cancer patients

TP53功能丧失改变对转移性去势抵抗性前列腺癌患者对PSMA放射配体治疗的反应的影响

THERANOSTICS
IF13.3
2024-01-010
OAAI
Slootbeek, Peter H. J.; Luna-Velez, Maria Victoria; Prive, Bastiaan M.; van der Doelen, Maarten J.; Kloots, Iris S. H.; Naga, Samhita Pamidimarri; Onstenk, Hilde E.; Nagarajah, James; Westdorp, Harm; van Oort, Inge M.; Kroeze, Leonie I.; Schalken, Jack. A.; Bloemendal, Haiko J.; Mehra, Niven
Fibroblast activation protein-targeted radionuclide therapy: background, opportunities, and challenges of first (pre)clinical studies

成纤维细胞活化蛋白靶向放射性核素治疗: 首次 (前) 临床研究的背景，机遇和挑战

European Journal of Nuclear Medicine and Molecular Imaging
IF7.6
2023-02-2355
OAAI
Prive, Bastiaan M. M.; Boussihmad, Mohamed A. A.; Timmermans, Bart; van Gemert, Willemijn A. A.; Peters, Steffie M. B.; Derks, Yvonne H. W.; van Lith, Sanne A. M.; Mehra, Niven; Nagarajah, James; Heskamp, Sandra; Westdorp, Harm
Immunophenotyping Reveals Longitudinal Changes in Circulating Immune Cells During Radium-223 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer

免疫表型分析揭示了转移性去势抵抗性前列腺癌患者镭223治疗期间循环免疫细胞的纵向变化

FRONTIERS IN ONCOLOGY
IF3.3
2021-05-1811
OAAI
Creemers, Joroen H. A.; van der Doelen, Maarten J.; van Wilpe, Sandra; Hermsen, Rick; Duiveman-de Boer, Tjitske; Somford, Diederik M.; Janssen, Marcel J. R.; Sedelaar, J. P. Michiel; Mehra, Niven; Textor, Johannes; Westdorp, Harm

研究方向

暂未获取到该数据
I
I. Jolanda M. de Vries
H 指数:77论文数:420被引数:2.1万
W
Winald R. Gerritsen
H 指数:54论文数:295被引数:1.4万
G
Gerty Schreibelt
H 指数:46论文数:184被引数:7,272
C
Carl G. Figdor
H 指数:124论文数:878被引数:5.7万
N
Niven Mehra
H 指数:45论文数:469被引数:9,181
K
Kalijn F. Bol
H 指数:26论文数:130被引数:2,894
S
Steve Boudewijns
H 指数:10论文数:24被引数:347
E
Erik H.J.G. Aarntzen
H 指数:39论文数:279被引数:5,030
M
Mark A.J. Gorris
H 指数:21论文数:106被引数:2,541
M
Michelle M. van Rossum
H 指数:35论文数:181被引数:4,240